NUCB2 and colonic neoplasm: After determining the role of nesfatin-1/NUCB-2 in clinical tumor samples, serum samples, a cell line, an animal tumor model, and an online microarray dataset, our results indicated nesfatin-1/NUCB-2 was a potential biomarker for prediction of metastasis in colon cancer.